7β-(3-Ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone

CAS : 80514-14-3

Ref. 3D-FDA51414

Informations sur le produit

• Nom: 7β-(3-Ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone
• Synonymes: 7β-[3′-Ethylcrotonoyloxy]-1α-[2′-methylbutyryloxy]-3, 14-dehydro-Z-notonipetranone, 2-Pentenoic acid, 3-methyl-, (1Z,3S,3aR,5R,7S,7aS)-1-ethylideneoctahydro-4-methylene-7-(1-methylethyl)-3-(2-methyl-1-oxobutoxy)-2-oxo-1H-inden-5-yl ester, (2E)-

Description

7β-(3-Ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone is a medicinal compound with potent anticancer properties. It has been shown to induce apoptosis and inhibit cell cycle progression in various cancer cell lines. The compound functions as a kinase inhibitor, blocking the activity of specific proteins involved in cancer cell growth and proliferation. Studies have demonstrated the effectiveness of 7β-(3-Ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone against leukemia cells and other types of cancer. This powerful inhibitor shows promise as a potential treatment for cancer patients, and further research is being conducted to explore its therapeutic potential.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 430.6 g/mol
• Formule: C₂₆H₃₈O₅
• Degré de pureté: Min. 95%